Phase 3 Anxiety Disorder Clinical Trials
16 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–16 of 16 trials
Recruiting
Phase 3
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Social Anxiety Disorder (SAD)
VistaGen Therapeutics, Inc.236 enrolled26 locationsNCT06615557
Recruiting
Phase 3
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
Social Anxiety Disorder (SAD)
Vanda Pharmaceuticals500 enrolled29 locationsNCT07221578
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
General Anxiety Disorder
Psicofarma, S.A. De C.V.162 enrolled1 locationNCT07477990
Recruiting
Phase 3
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Generalized Anxiety Disorder
Definium Therapeutics US, Inc.250 enrolled38 locationsNCT06809595
Recruiting
Phase 3
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
Anxiety DisordersGeneralized Anxiety Disorder (GAD)
Wayne State University90 enrolled1 locationNCT07123467
Recruiting
Phase 3
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Generalized Anxiety Disorder
Definium Therapeutics US, Inc.200 enrolled36 locationsNCT06741228
Recruiting
Phase 2Phase 3
Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
DepressionPost Traumatic Stress DisorderAnxiety Disorders
University of California, San Diego128 enrolled1 locationNCT06273527
Recruiting
Phase 3
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
AnxietySocial Anxiety DisorderADHD+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.308 enrolled47 locationsNCT06973577
Recruiting
Phase 2Phase 3
Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi Arabia
Depression Anxiety Disorder
Roaa Ahmed Alkreadees60 enrolled1 locationNCT06765057
Not Yet Recruiting
Phase 3
PAPAYA: Pharmacologically-Assisted Psychotherapy for social Anxiety in Young people with Autism
Autism Spectrum DisorderSocial Anxiety Disorder
Orygen156 enrolled1 locationACTRN12624001474549
Recruiting
Phase 3
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
Generalized Anxiety Disorder
Sichuan Jishengtang Pharmaceutical Co., Ltd.495 enrolled1 locationNCT05772104
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Generalized Anxiety Disorder
Luye Pharma Group Ltd.555 enrolled1 locationNCT05970510
Recruiting
Phase 3
Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Generalized Anxiety Disorder
Beijing Union Pharmaceutical Factory Ltd410 enrolled1 locationNCT06243614
Recruiting
Phase 3
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Generalized Anxiety Disorder
Beijing Union Pharmaceutical Factory Ltd504 enrolled1 locationNCT06243640
Completed
Phase 2Phase 3
The use of tiagabine and gabapentin in the treatment of social anxiety disorder in 8 patients
Subjects with social anxiety disorder
Maria Urbano, M.D.8 enrolled1 locationACTRN12609000091202
Completed
Phase 3
Effects of Oxytocin on Amygdala Response to Threat in Generalised Social Anxiety Disorder: A Functional Magnetic Resonance Imaging (fMRI) Study
Generalised Social Anxiety Disorder
School of Psychology, Psychiatry and Psychological Medicine, Monash University40 enrolled1 locationACTRN12607000141448